Did you hear the news?The American College of Radiology (ACR) and the Society for Pediatric Radiology (SPR) have just updated the Practice Parameter for the performance of the Modified Barium Swallow Study (MBSS).It’s true, the new 2023 ACR/SPR Practice Parameter for MBSS is out—and there’s a lot to it! Compared with the 2017 version, this update has new recommendations, more detail, and greater emphasis on standardization across the board. Here are some examples:

  • Standardized and validated protocols, assessments, interpretation, and reporting are encouraged¹
  • A standardized and validated set of commercially prepared barium consistencies and volumes is recommended¹
  • Acknowledgment that the literature supports a fluoroscopic acquisition rate of 30 pulses per second or continuous fluoroscopy whenever possible to provide optimal visualization of rapid movements associated with swallowing and aspiration detection¹

 

 

Click here for a PDF of the complete 2023 ACR/SPR Practice Parameter for MBSS and then make sure to share with your radiology colleagues.
READ THE GUIDELINES

 

 

INDICATIONS AND USAGE | IMPORTANT SAFETY INFORMATION

VARIBAR® (barium sulfate)

IMPORTANT SAFETY INFORMATION:

For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

INDICATIONS AND USAGE | IMPORTANT SAFETY INFORMATION

VARIBAR® (barium sulfate)

Indications and Usage:

VARIBAR® THIN HONEY (barium sulfate) oral suspension, VARIBAR® NECTAR (barium sulfate) oral suspension, and VARIBAR® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR® HONEY (barium sulfate) oral suspension and VARIBAR® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:

For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please consult full Prescribing Information for VARIBAR HONEY here, for VARIBAR THIN HONEY here, for VARIBAR PUDDING here, for VARIBAR NECTAR here, and for VARIBAR THIN LIQUID here.

VARIBAR is manufactured by E-Z-EM Canada Inc., for E-Z-EM, Inc., a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 08831.

VARIBAR is a registered trademark of E-Z-EM, Inc.

See you soon,

Reference:1. The American College of Radiology. ACR–SPR Practice Parameter for the Performance of the Modified Barium Swallow. 2023. 

US-VARH-2300014 10/23